Viewing 0 reply threads
  • Author
    • #16613

      PTC Therapeutics will be hosting an Informational Patient Webinar on July 28th at 7pm EST to learn more about FA-743, a candidate molecule for the treatment of Friedreich’s Ataxia.

      The clinical trial for FA-743 will be international and include clinic sites in Australia, Brazil, Canada, the E.U., and the U.S.

      To pre-register for the webinar, please click here:

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2022 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?

Create Account